VSR Financial Services’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-32,404
Closed -$878K 560
2016
Q1
$878K Sell
32,404
-216
-0.7% -$5.79K 0.09% 243
2015
Q4
$947K Buy
32,620
+10,208
+46% +$283K 0.1% 223
2015
Q3
$608K Sell
22,412
-424
-2% -$12K 0.07% 274
2015
Q2
$625K Buy
22,836
+9,754
+75% +$274K 0.07% 300
2015
Q1
$349K Sell
13,082
-190
-1% -$4.38K 0.04% 412
2014
Q4
$281K Hold
13,272
0.03% 441
2014
Q3
$316K Hold
13,272
0.04% 430
2014
Q2
$307K Buy
13,272
+486
+4% +$10.7K 0.04% 425
2014
Q1
$292K Sell
12,786
-2,694
-17% -$57.4K 0.04% 446
2013
Q4
$286K Buy
15,480
+170
+1% +$2.96K 0.04% 433
2013
Q3
$259K Buy
+15,310
New +$258K 0.05% 422

Other funds holding NVO

VSR Financial Services's NVO Position: Q2 2016 in Review

VSR Financial Services sold out of Novo Nordisk (NVO) in Q2 2016, closing a stake of 32,404 shares — an estimated $878K sold.

VSR Financial Services first reported a position in NVO in Q3 2013 and held it in 11 quarters. The position peaked at $947K in Q4 2015. 529 funds tracked by Wall St. Rank hold NVO as of Q2 2016.

  • VSR Financial Services reported no remaining Novo Nordisk position as of Q2 2016 after selling out during the quarter.
  • VSR Financial Services sold 32,404 Novo Nordisk shares in Q2 2016, an estimated $878K.
  • VSR Financial Services first reported a position in Novo Nordisk in Q3 2013 and held it in 11 quarters.
  • VSR Financial Services's Novo Nordisk position peaked at $947K in Q4 2015.
  • 529 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2016.

Based on VSR Financial Services's 13F filing for Q2 2016, filed 11 Aug 2016.